Article thumbnail

Glucose-dependent insulinotropic peptide receptor overexpression in adrenocortical hyperplasia in MEN1 syndrome without loss of heterozygosity at the 11q13 locus

By Marcia Helena Soares Costa, Sorahia Domenice, Rodrigo Almeida Toledo, Delmar Muniz Lourenço, Ana Claudia Latronico, Emilia Modolo Pinto, Sergio Pereira Almeida Toledo, Berenice Bilharinho Mendonca and Maria Candida Barisson Villares Fragoso
Topics: Clinical Science
Publisher: Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. A genome-wide scan identifies mutations in the gene encoding phosphodiesterase 11A4 (PDE11A) in individuals with adrenocortical hyperplasia.
  2. Adrenal involvement in multiple endocrine neoplasia type 1: results of 7 years prospective screening. Langenbecks Arch Surg.
  3. (2002). Adrenal involvement in multiple endocrine neoplasia type 1. World
  4. (1995). Adrenal lesion in multiple endocrine neoplasia type 1.
  5. (1996). Adrenal lesions in a large kindred with multiple endocrine neoplasia type 1. Arch Surg.
  6. (1998). Adrenocortical overexpression of gastric inhibitory polypeptide receptor underlies food-dependent Cushing’s syndrome.
  7. (1992). Aldosterone-secreting adrenal adenoma as part of multiple endocrine neoplasia type 1 (MEN1): loss of heterozygosity for polymorphic chromosome 11 deoxyribonucleic acid markers, including the MEN1 locus.
  8. Analysis of glucosedependent insulinotropic peptide receptor (GIPR) and luteinizing hormone receptor (LHCGR) expression in human adrenocortical hyperplasia. Arq Bras Endocrinol Metabol.
  9. Analysis of relative gene expression data using real-time quantitative
  10. (1992). Clinical and genetic features of adrenocortical lesions in multiple endocrine neoplasia type 1. J Clin Endocrinol Metab.
  11. Cushing’s syndrome secondary to ACTHindependent macronodular adrenal hyperplasia. Arq Bras Endocrinol Metabol.
  12. Cushing’s syndrome variants secondary to aberrant hormone receptors. Trends Endocrinol Metab.
  13. Ectopic expression of the gastric inhibitory polypeptide receptor gene is a sufficient genetic GIPR overexpression
  14. (2006). Expression of ACTH receptor pathway genes in glucose-dependent insulinotrophic peptide (GIP)-dependent Cushing’s syndrome. Clin Endocrinol (Oxf).
  15. (1998). Expression of the MEN-1 gene in a large kindred with multiple endocrine neoplasia type 1.
  16. Food-dependent androgen and cortisol secretion by a gastric inhibitory polypeptide-receptor expressive adrenocortical adenoma leading to hirsutism and subclinical Cushing’s syndrome: in vivo and in vitro studies.
  17. (2000). Functional collaboration between different cyclin-dependent kinase inhibitors suppresses tumor growth with distinct tissue specificity. Mol Cell Biol.
  18. Functional studies of the MEN1 gene.
  19. (1997). Gastric inhibitory polypeptide activates MAP kinase through the wortmannin-sensitive and -insensitive pathways. Biochem Biophys Res Commun.
  20. (2001). Glucose-dependent insulinotropic polypeptide is a growth factor for beta (INS-1) cells by pleiotropic signaling. Mol Endocrinol.
  21. GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours.
  22. Guidelines for diagnosis and therapy
  23. In vivo and in vitro screening for illegitimate receptors in adrenocorticotropin-independent macronodular adrenalhyperplasiacausingCushing’ssyndrome:identificationoftwocases of gonadotropin/gastric inhibitory polypeptide-dependent hypercortisolism.
  24. Isolated familial somatotropinoma: 11q13-loh and gene/protein expression analysis suggests a possible involvement of aip also in non-pituitary tumorigenesis. Clinics (Sao Paulo).
  25. (2005). Lessons from genes mutated in multiple endocrine neoplasia (MEN) syndromes. Ann Endocrinol
  26. (1991). Loss of heterozygosity on the short arm of chromosome 17 is associated with high proliferative capacity and DNA aneuploidy in primary human breast cancer.
  27. (1999). MEN1 gene mutation analysis of sporadic adrenocortical lesions.
  28. Menin and MLL cooperatively regulate expression of cyclin-dependent kinase inhibitors.
  29. Menin regulates pancreatic islet growth by promoting histone methylation and expression of genes encoding
  30. Molecular pathology of the MEN1 gene.
  31. Multiple endocrine neoplasia. Horm Res.
  32. Mutation and cancer: statistical study of retinoblastoma.
  33. Mutation in PDE8B, a cyclic AMPspecific phosphodiesterase in adrenal hyperplasia.
  34. Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex.
  35. Natural course of small adrenal lesions in multiple endocrine neoplasia type 1: an endoscopic ultrasound imaging study.